Perk, L R, Vosjan, M J W D, Visser, G W M, Budde, M, Jurek, P, Kiefer, G E & van Dongen, G A M S 2010, ' p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 2, pp. 250-259 . https://doi.org/10.1007/s00259-009-1263-1 European Journal of Nuclear Medicine and Molecular Imaging European Journal of Nuclear Medicine and Molecular Imaging, 37(2), 250-259. Springer Verlag
Clinical Cancer Research, 12(7 I), 2133-2140. American Association for Cancer Research Inc. Börjesson, P K E, Jauw, Y W S, Boellaard, R, De Bree, R, Comans, E F I, Roos, J C, Castelijns, J A, Vosjan, M J W D, Kummer, J A, Leemans, C R, Lammertsma, A A & Van Dongen, G A M S 2006, ' Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients ', Clinical Cancer Research, vol. 12, no. 7 I, pp. 2133-2140 . https://doi.org/10.1158/1078-0432.CCR-05-2137
European Journal of Nuclear Medicine and Molecular Imaging, 31(12), 1645-1652. Springer Verlag Verel, I, Visser, G W M, Vosjan, M J W D, Finn, R, Boellaard, R & Van Dongen, G A M S 2004, ' High-quality 124 I-labelled monoclonal antibodies for use as PET scouting agents prior to 131 I-radioimmunotherapy ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 31, no. 12, pp. 1645-1652 . https://doi.org/10.1007/s00259-004-1632-8
Verel, I, Visser, G W M, Boerman, O C, Van Eerd, J E M, Finn, R, Boellaard, R, Vosjan, M J W D, Stigter-Van Walsum, M, Snow, G B & Van Dongen, G A M S 2003, ' Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET ', Cancer Biotherapy and Radiopharmaceuticals, vol. 18, no. 4, pp. 655-661 . https://doi.org/10.1089/108497803322287745 Cancer Biotherapy & Radiopharmaceuticals, 18, 4, pp. 655-61 Cancer Biotherapy & Radiopharmaceuticals, 18, 655-61 Cancer Biotherapy and Radiopharmaceuticals, 18(4), 655-661. Mary Ann Liebert Inc.
Vosjan, M J W D, Vercammen, J, Kolkman, J A, Stigter-van Walsum, M, Revets, H & van Dongen, G A M S 2012, ' Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy ', Molecular Cancer Therapeutics, vol. 11, no. 4, pp. 1017-1025 . https://doi.org/10.1158/1535-7163.MCT-11-0891 Molecular Cancer Therapeutics, 11(4), 1017-1025. American Association for Cancer Research Inc.
Rizvi, S N F, Visser, O, Vosjan, M J W D, van Lingen, A, Hoekstra, O S, Zijlstra-Baalbergen, J M, Huijgens, P C, van Dongen, G A M S & Lubberink, J M 2012, ' Biodistribution, radiation dosimetry and scouting of Y-90-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using Zr-89-ibritumomab tiuxetan and PET ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 39, no. 3, pp. 512-520 . https://doi.org/10.1007/s00259-011-2008-5 European Journal of Nuclear Medicine and Molecular Imaging European Journal of Nuclear Medicine and Molecular Imaging, 39(3), 512-520. Springer Verlag